⌘K
OverviewStock screenerAnalyst actionsCalendar
MarketsInvestorsSign in
StockUnited StatesNYSE

AVTR

Avantor, Inc.

Healthcare · Medical Instruments & Supplies

14.88USD

-0.3700 (-2.43%)

DescriptionHistoricalFinancialsRelative ValueResearchNewsDiscussionOptionsPrice Chart ↗Fundamental Chart ↗

Estimates and surprises

Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.

PeriodConsensus EPS90 days agoRevisions up (30d)Revisions down (30d)
Current quarter$0.21▲$0.281
Next quarter$0.22▼$0.2315
Current year$0.81▲$0.79150
Next year$0.88▲$0.85140

Recent quarters

Beat in 3 of the last 4

QuarterEstimateActualSurprise
2026-06-30$0.19$0.21+0.02 (+11.1%)
2026-03-31$0.16$0.17+0.01 (+8.2%)
2025-12-31$0.22$0.22+0.00 (+1.5%)
2025-09-30$0.23$0.22-0.01 (-2.3%)

Wall Street coverage

212 ratings from 26 firms

Ratings are attributed to the research firm, not to individual analysts. See every ticker.

FirmActionRatingPrice TargetDate
UBSMaintainedNeutral$10.5 $16Sep 9, 2026
Morgan StanleyMaintainedEqual-Weight$10 $14Jul 30, 2026
RBC CapitalMaintainedSector Perform$9 $14Jul 30, 2026
StifelMaintainedHold$8 $15Jul 30, 2026
Evercore ISI GroupMaintainedIn-Line$10.5 $14Jul 30, 2026
Wells FargoMaintainedOverweight$14 $16Jul 30, 2026
CitigroupMaintainedNeutral$9 $11Jul 8, 2026
Evercore ISI GroupMaintainedIn-Line$8 $10.5Jul 6, 2026
BarclaysMaintainedUnderweight$7 $8Jun 24, 2026
CitigroupMaintainedNeutral$11 $9Apr 30, 2026
Evercore ISI GroupMaintainedIn-Line$8.5 $8Apr 30, 2026
BarclaysMaintainedUnderweight$8.5 $7Apr 15, 2026
Evercore ISI GroupMaintainedIn-Line$10 $8.5Apr 6, 2026
BarclaysDowngraded from Equal-WeightUnderweight$8.5Mar 6, 2026
Wells FargoMaintainedOverweight$16 $14Feb 13, 2026
CitigroupMaintainedNeutral$13 $11Feb 12, 2026
BarclaysMaintainedEqual-Weight$12 $9Feb 12, 2026
TD CowenMaintainedHold$14 $12Jan 7, 2026
Evercore ISI GroupDowngraded from OutperformIn-Line$14 $12Jan 5, 2026
JefferiesDowngraded from HoldUnderperform$12 $9Dec 17, 2025
Evercore ISI GroupMaintainedOutperform$16 $14Oct 30, 2025
BarclaysDowngraded from OverweightEqual-Weight$15 $12Oct 30, 2025
JP MorganDowngraded from OverweightNeutral$14 $12Oct 30, 2025
BairdMaintainedOutperform$15 $17Oct 24, 2025
Raymond JamesMaintainedOutperform$14 $16Oct 16, 2025

Insider transactions

69 filings from 24 insiders · 18 buy / 4 sell over 6m

Officers and directors of AVTR, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.

InsiderActionSharesPriceValueDate
LUCIER GREGORY TDirectorBuyindirect10.0k$8.32$83kMay 8, 2026
MEHRA SANJEEV KDirectorGrant25.3k——May 7, 2026
LUCIER GREGORY TDirectorGrant25.3k——May 7, 2026
MURTHY MALADirectorGrant25.3k——May 7, 2026
MAKIN LOUISEDirectorGrant25.3k——May 7, 2026
DINGEMANS SIMONDirectorGrant25.3k——May 7, 2026
SUMME GREGORY LDirectorGrant25.3k——May 7, 2026
MASSARO JOSEPH RDirectorGrant25.3k——May 7, 2026
SEVERINO MICHAEL EDirectorGrant25.3k——May 7, 2026
DINGEMANS SIMONDirectorBuyindirect25.0k$8.14$204kMay 1, 2026
BRELLIER LUDOVICOfficerGrant146.6k——May 1, 2026
ECK STEVEN W.OfficerGrant31.6k——Apr 2, 2026
MEHRA SANJEEV KDirectorBuyindirect125.0k$8.01$1.00MMar 10, 2026
LUCIER GREGORY TDirectorBuyindirect50.0k$9.16$458kFeb 19, 2026
SOKENU CLAUDIUS O.OfficerGrant80.6k——Feb 19, 2026
HANKAMER BRITTANYOfficerGrant80.6k——Feb 19, 2026
WALKER COREYOfficerGrant161.2k——Feb 19, 2026
GOURDIER BENOITOfficerGrant134.4k——Feb 19, 2026
LIGNER EMMANUELChief Executive OfficerGrant483.7k——Feb 19, 2026
BLENN MARYChief Operating OfficerGrant236.0k——Feb 19, 2026

Analyst Notes

Sign in to write

No analyst notes on AVTR yet.

Analyst Ratings

14 analysts covering

PeriodStrong BuyBuyHoldSellStrong SellConsensus
Current031201Hold2.94
1 mo ago031201Hold2.94
2 mo ago031121Hold3.06
Price target$14.56$12.00 – $19.00
-2.1% to target